hydrazine has been researched along with Acute Confusional Senile Dementia in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 9 (39.13) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, MH; Nam, G; Suh, JM; Yi, Y | 1 |
| Apaydın, ÇB; Demir-Yazıcı, K; Karalı, N; Özsoy, N; Soylu-Eter, Ö | 1 |
| Abid, A; Eijaz, S; Lateef, M; Rafiq, N; Tauseef, S | 1 |
| Kaplancıklı, ZA; Koçyiğit-Kaymakçıoğlu, B; Özkay, Y; Sağlık, BN; Tok, F | 1 |
| Aki-Yalcin, E; Farouk, FM; Law, CSW; Muhammed, MT; Ooi, L; Ozturk, O; Yeong, KY | 1 |
| Buchholz, M; Demuth, HU; Diederichsen, U; Funk, LM; Kupski, O; Meyer, F; Ramsbeck, D; Sautner, V; Schilling, S; Seifert, F; Tittmann, K; Worbs, B | 1 |
| Buabeid, M; Dhanasekaran, M; Dwyer, D; Fabbrini, M; Fujihashi, A; Govindarajulu, M; Lynd, T; Mohanakumar, KP; Moore, T; Neel, L; Ramesh, S; Shah, K; Smith, F | 1 |
| Athar, MM; Awan, SJ; Iftikhar, K; Javid, N; Khan, I; Munir, R; Murtaza, S; Zaib, S; Zia-Ur-Rehman, M | 1 |
| Anisimov, AS; Charushin, VN; Chupakhin, ON; Dutysheva, EA; Guzhova, IV; Lazarev, VF; Margulis, BA; Trestsova, MA; Utepova, IA | 1 |
| Agoni, C; Emmanuel, IA; Olotu, FA; Soliman, MES | 1 |
| Hadjipavlou-Litina, D; Marco-Contelles, J; Samadi, A; Unzeta, M | 1 |
| Chiruta, C; Schubert, D; Tang, F; Wang, T; Zhao, Y | 1 |
| Melis, RJ; Rikkert, MG; Sjögren, MJ; Spies, PE; Verbeek, MM | 1 |
| Chen, YQ; Ji, TT; Jiang, X; Mei, B; Zhang, DL | 1 |
| Han, M; Liu, J; Liu, Y; Tan, Q; Wang, W; Wang, YY; Zhang, B; Zhang, JM; Zhang, XJ | 1 |
| Heyny-von Haussen, R; Mall, G; Mandelkow, E; Mandelkow, EM; Nasir, S; Pickhardt, M; Schmidt, B; Taghavi, A | 1 |
| Dobrowolski, P; Doré, S; Kapoor, N; Kim, YT; Langer, J; Li, RC; Maruyama, T; Narumiya, S; Yocum, J; Zhen, G | 1 |
| Gao, M; Wang, M; Zheng, QH | 1 |
| Arancio, O; Jacob, JP; Palmeri, A; Puzzo, D; Trinchese, F; Vitolo, O | 1 |
| Boyd-Kimball, D; Butterfield, DA; Cai, J; Klein, JB; Markesbery, WR; Merchant, M; Pierce, WM; Poon, HF; Sultana, R | 1 |
| Blankenberg, FG; Gilad, R; Lampl, Y; Lorberboym, M; Sadeh, M | 1 |
| Mikiciuk-Olasik, E; Szymański, P; Zurek, E | 1 |
| Sparkman, DR | 1 |
1 review(s) available for hydrazine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Animals; Biphenyl Compounds; Dietary Supplements; Drug Delivery Systems; Enzyme Inhibitors; Glucosides; Humans; Hydrazines; Indazoles; Lignans; Neuroprotection; Phenols; Sirtuin 3 | 2021 |
22 other study(ies) available for hydrazine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Drug repurposing: small molecules against Cu(II)-amyloid-β and free radicals.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Copper; Drug Repositioning; Free Radicals; Humans; Hydrazines; Iproniazid; Isoniazid; Metals; Molecular Weight; Protein Aggregates; Reactive Oxygen Species; Small Molecule Libraries; Tandem Mass Spectrometry | 2021 |
Synthesis, molecular modeling and cholinesterase inhibitory effects of 2-indolinone-based hydrazinecarbothioamides.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Hydrazines; Models, Molecular; Molecular Structure; Oxindoles; Thioamides | 2021 |
Multi-activity tetracoordinated pallado-oxadiazole thiones as anti-inflammatory, anti-Alzheimer, and anti-microbial agents: Structure, stability and bioactivity comparison with pallado-hydrazides.
Topics: Alzheimer Disease; Anti-Infective Agents; Anti-Inflammatory Agents; Bacteria; Cholinesterase Inhibitors; Fungi; Hydrazines; Lipoxygenase Inhibitors; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxadiazoles; Palladium; Structure-Activity Relationship; Thiones | 2022 |
N-Substituted Arylidene-3-(Methylsulfonyl)-2-Oxoimidazolidine-1-Carbohydrazide as Cholinesterase Inhibitors: Design, Synthesis, and Molecular Docking Study.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Enzyme Inhibitors; Humans; Hydrazines; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2022 |
Synthesis of novel carboxamide- and carbohydrazide-benzimidazoles as selective butyrylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Benzimidazoles; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Hydrazines; Molecular Docking Simulation; Structure-Activity Relationship | 2022 |
Hydrazides Are Potent Transition-State Analogues for Glutaminyl Cyclase Implicated in the Pathogenesis of Alzheimer's Disease.
Topics: Alzheimer Disease; Aminoacyltransferases; Crystallography, X-Ray; Cyclization; Enzyme Inhibitors; Humans; Hydrazines; Models, Molecular; Molecular Targeted Therapy; Neurotensin; Protein Conformation | 2020 |
Microwave-Assisted Synthesis of (Piperidin-1-yl)quinolin-3-yl)methylene)hydrazinecarbothioamides as Potent Inhibitors of Cholinesterases: A Biochemical and In Silico Approach.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cell Line, Tumor; Cell Proliferation; Cholinesterase Inhibitors; Cholinesterases; Hep G2 Cells; Heterocyclic Compounds; Humans; Hydrazines; Microwaves; Molecular Docking Simulation; Quinolines; Structure-Activity Relationship; Thioamides | 2021 |
Synthesis and approbation of new neuroprotective chemicals of pyrrolyl- and indolylazine classes in a cell model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Apoptosis; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Hydrazines; Molecular Structure; Neurons; Neuroprotective Agents; Pyrroles; Structure-Activity Relationship | 2021 |
Deciphering the 'Elixir of Life': Dynamic Perspectives into the Allosteric Modulation of Mitochondrial ATP Synthase by J147, a Novel Drug in the Treatment of Alzheimer's Disease.
Topics: Allosteric Regulation; Alzheimer Disease; Binding Sites; Catalytic Domain; Curcumin; Humans; Hydrazines; Mitochondria; Mitochondrial Proton-Translocating ATPases; Molecular Docking Simulation; Principal Component Analysis; Static Electricity; Thermodynamics | 2019 |
Analysis of the antioxidant properties of differently substituted 2- and 3-indolyl carbohydrazides and related derivatives.
Topics: Alzheimer Disease; Animals; Antioxidants; Biocatalysis; Biphenyl Compounds; Carrageenan; Edema; Female; Free Radical Scavengers; Humans; Hydrazines; Lipid Peroxidation; Lipoxygenase; Male; Molecular Structure; Oxidation-Reduction; Picrates; Rats; Rats, Inbred F344; Structure-Activity Relationship | 2013 |
Metabolism of a potent neuroprotective hydrazide.
Topics: Alzheimer Disease; Animals; Drug Discovery; Humans; Hydrazines; Male; Mice; Mice, Inbred BALB C | 2013 |
Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Dementia, Vascular; Female; Humans; Hydrazines; Lewy Body Disease; Male | 2009 |
Oxidative damage increased in presenilin1/presenilin2 conditional double knockout mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Animals; Deoxyguanosine; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glutathione; Hydrazines; Lipid Peroxidation; Malondialdehyde; Mice; Mice, Inbred CBA; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Peptide Fragments; Presenilin-1; Presenilin-2; Spectrophotometry, Atomic; Superoxide Dismutase | 2009 |
Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; CA1 Region, Hippocampal; Dentate Gyrus; Disease Models, Animal; Dose-Response Relationship, Drug; Hydrazines; Injections; Memory Disorders; Neurons; Neuroprotective Agents; Oxadiazoles; Peptide Fragments; Protein Multimerization; Protein Structure, Secondary; Rats; Rats, Wistar | 2011 |
N'-benzylidene-benzohydrazides as novel and selective tau-PHF ligands.
Topics: Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Female; Humans; Hydrazines; Indoles; Inhibitory Concentration 50; Ligands; Male; Neurofibrillary Tangles; Peptide Fragments; Plaque, Amyloid; tau Proteins | 2011 |
PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Brain; Brain Ischemia; Calcium; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glucose; Hippocampus; Humans; Hydrazines; Hypoxia; Male; Mice; Mice, Transgenic; Neurons; Neurotoxicity Syndromes; Oxazepines; Peptide Fragments; Presenilin-1; Receptors, Prostaglandin E, EP1 Subtype | 2012 |
The first synthesis of [11C]J147, a new potential PET agent for imaging of Alzheimer's disease.
Topics: Alzheimer Disease; Chromatography, High Pressure Liquid; Humans; Hydrazines; Hydrocarbons, Fluorinated; Molecular Structure; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cyclic AMP Response Element-Binding Protein; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Fluorescent Antibody Technique; Guanylate Cyclase; Hippocampus; Hydrazines; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Organ Culture Techniques; Peptide Fragments; Phosphorylation; Up-Regulation | 2005 |
Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blotting, Western; Cerebellum; Electrophoresis, Gel, Two-Dimensional; Female; Hippocampus; Humans; Hydrazines; Immunoprecipitation; Male; Mass Spectrometry; Matched-Pair Analysis; Oxidation-Reduction; Oxidative Stress; Proteins; Proteomics; Trypsin | 2006 |
Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Annexin A5; Dementia; Dementia, Vascular; Female; Humans; Hydrazines; Injections, Intravenous; Lewy Body Disease; Ligands; Magnetic Resonance Imaging; Male; Middle Aged; Nicotinic Acids; Phosphatidylserines; Pilot Projects; Technetium; Tomography, Emission-Computed, Single-Photon | 2006 |
New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Hydrazines; Indicators and Reagents; Kinetics; Niacinamide; Radiopharmaceuticals; Tacrine; Technetium Compounds | 2006 |
Dansyl hydrazine labeling of polysaccharide bodies in human brain.
Topics: Aging; Alzheimer Disease; Brain Chemistry; Dansyl Compounds; Epilepsies, Myoclonic; Fluorescent Dyes; Humans; Hydrazines; Polysaccharides; Staining and Labeling | 1993 |